This inventor holds 1 USPTO granted patent. Top assignee: Vsesojuzny Nauchno-Issledovatelsky Institut Genetiki. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: The Innovations of Sergei G. Arsenian
Introduction
Sergei G. Arsenian is a notable inventor based in Moscow, Russia. He is recognized for his contributions to biotechnology, particularly in the field of human leukocyte interferon production. His innovative methods have paved the way for advancements in medical treatments and therapies.
Latest Patents
Arsenian holds a patent for a method of producing human leukocyte interferon alpha-2. This method involves submerged cultivation of a producer strain, Pseudomonas species VG-84, which carries a plasmid with the inserted gene of human leukocyte interferon alpha-2. The strain is cultivated in a nutrient medium containing sources of carbon and nitrogen, mineral salts, and growth stimulants, under aeration and in the presence of antibiotics. The process concludes with the isolation and purification of the end product. He has 1 patent to his name.
Career Highlights
Arsenian has made significant strides in his career, working at the Vsesoyuzny Nauchno-Issledovatelsky Institut Genetiki. His work has been instrumental in advancing genetic research and biotechnological applications. His innovative approach to interferon production has garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include Vladimir G. Debabov and Jury Dmitrievich Tsygankov. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Sergei G. Arsenian's contributions to biotechnology and his innovative methods for producing human leukocyte interferon alpha-2 highlight his importance as an inventor. His work continues to influence the field and offers promising avenues for future research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile